Success Metrics

Clinical Success Rate
55.6%

Based on 5 completed trials

Completion Rate
56%(5/9)
Active Trials
0(0%)
Results Posted
160%(8 trials)
Terminated
4(44%)

Phase Distribution

Ph phase_2
1
11%
Ph phase_1
8
89%

Phase Distribution

8

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
8(88.9%)
Phase 2Efficacy & side effects
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

55.6%

5 of 9 finished

Non-Completion Rate

44.4%

4 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(5)
Terminated(4)

Detailed Status

Completed5
Terminated4

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
55.6%
Most Advanced
Phase 2

Trials by Phase

Phase 18 (88.9%)
Phase 21 (11.1%)

Trials by Status

terminated444%
completed556%

Recent Activity

0 active trials
Showing 5 of 9
terminatedphase_1

A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

NCT05671653
terminatedphase_1

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

NCT05788328
terminatedphase_1

A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction

NCT05510245
completedphase_1

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

NCT05745701
completedphase_1

A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction

NCT05478603
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05671653Phase 1

A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range

Terminated
NCT05788328Phase 1

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants

Terminated
NCT05510245Phase 1

A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction

Terminated
NCT05745701Phase 1

A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacokinetics in Overweight or Obese Adults

Completed
NCT05478603Phase 1

A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction

Completed
NCT05158244Phase 1

Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Completed
NCT05579977Phase 2

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Terminated
NCT04305587Phase 1

Multiple Escalating Oral Doses Study of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus

Completed
NCT04148209Phase 1

Study of Single Ascending Doses of PF-07081532 in Healthy Adult Participants

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9